On the brink of extinction: the future of translational physician-scientists in the United States

Journal of Translational Medicine

Commentary

Hideki Furuya¹  Charles J. Rosser¹  Dean Brenner² 

[1] Clinical and Translational Research Program, University of Hawaii Cancer Center, 701 Ilalo St, Rm 327, 96813, Honolulu, HI, USA;Division of Hematology-Oncology, Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, USA;

关键词: Translational research;    Physician-scientist;    Career;    Funding;    NIH;   

DOI  :  10.1186/s12967-017-1188-6

 received in 2017-04-03, accepted in 2017-04-20,  发布年份 2017

来源: Springer

【 摘 要 】

Over the past decade, we have seen an unparalleled growth in our knowledge of cancer biology and the translation of this biology into a new generation of therapeutic tools that are changing cancer treatment outcomes. With the continued explosion of new biologic discoveries, we find ourselves with a limited number of trained and engaged translational physician-scientists capable of bridging the chasm between basic science and clinical science. Here, we discuss the current state translational physician-scientists find themselves in and offer solutions to navigate during this difficult time.

【 授权许可】

CC BY   
© The Author(s) 2017